132 related articles for article (PubMed ID: 24962030)
1. Unbound fraction of ertapenem in intensive care unit patients.
Liebchen U; Kratzer A; Wicha SG; Kees F; Kloft C; Kees MG
J Antimicrob Chemother; 2014 Nov; 69(11):3108-11. PubMed ID: 24962030
[TBL] [Abstract][Full Text] [Related]
2. Protein binding characteristics and pharmacokinetics of ceftriaxone in intensive care unit patients.
Schleibinger M; Steinbach CL; Töpper C; Kratzer A; Liebchen U; Kees F; Salzberger B; Kees MG
Br J Clin Pharmacol; 2015 Sep; 80(3):525-33. PubMed ID: 25808018
[TBL] [Abstract][Full Text] [Related]
3. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T
J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
Brink AJ; Richards GA; Schillack V; Kiem S; Schentag J
Int J Antimicrob Agents; 2009 May; 33(5):432-6. PubMed ID: 19091521
[TBL] [Abstract][Full Text] [Related]
5. Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis.
Burkhardt O; Brunner M; Schmidt S; Grant M; Tang Y; Derendorf H
J Antimicrob Chemother; 2006 Sep; 58(3):632-6. PubMed ID: 16840426
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of ertapenem in critically ill patients with acute renal failure undergoing extended daily dialysis.
Burkhardt O; Hafer C; Langhoff A; Kaever V; Kumar V; Welte T; Haller H; Fliser D; Kielstein JT
Nephrol Dial Transplant; 2009 Jan; 24(1):267-71. PubMed ID: 18723863
[TBL] [Abstract][Full Text] [Related]
7. Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1 gram/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers.
Wiskirchen DE; Housman ST; Quintiliani R; Nicolau DP; Kuti JL
Pharmacotherapy; 2013 Mar; 33(3):266-74. PubMed ID: 23400916
[TBL] [Abstract][Full Text] [Related]
8. Assay methodology for the quantitation of unbound ertapenem, a new carbapenem antibiotic, in human plasma.
Musson DG; Birk KL; Kitchen CJ; Zhang J; Hsieh JY; Fang W; Majumdar AK; Rogers JD
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jan; 783(1):1-9. PubMed ID: 12450519
[TBL] [Abstract][Full Text] [Related]
9. Unbound fraction of vancomycin in intensive care unit patients.
Kees MG; Wicha SG; Seefeld A; Kees F; Kloft C
J Clin Pharmacol; 2014 Mar; 54(3):318-23. PubMed ID: 24000044
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Saux MC; Gordien JB; Allaouchiche B
Intensive Care Med; 2006 Dec; 32(12):2059-62. PubMed ID: 17039351
[TBL] [Abstract][Full Text] [Related]
11. Determination of free vancomycin, ceftriaxone, cefazolin and ertapenem in plasma by ultrafiltration: impact of experimental conditions.
Kratzer A; Liebchen U; Schleibinger M; Kees MG; Kees F
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 961():97-102. PubMed ID: 24878831
[TBL] [Abstract][Full Text] [Related]
12. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
[TBL] [Abstract][Full Text] [Related]
13. A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection.
Briscoe SE; McWhinney BC; Lipman J; Roberts JA; Ungerer JP
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():178-84. PubMed ID: 23026224
[TBL] [Abstract][Full Text] [Related]
14. Assay of ertapenem in human serum by high-performance liquid chromatography.
Soltani M; MacGowan AP; Lovering AM
Int J Antimicrob Agents; 2006 Feb; 27(2):165-7. PubMed ID: 16417992
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ertapenem in healthy young volunteers.
Majumdar AK; Musson DG; Birk KL; Kitchen CJ; Holland S; McCrea J; Mistry G; Hesney M; Xi L; Li SX; Haesen R; Blum RA; Lins RL; Greenberg H; Waldman S; Deutsch P; Rogers JD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3506-11. PubMed ID: 12384357
[TBL] [Abstract][Full Text] [Related]
16. Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
Bernareggi A; Borgonovi M; Del Favero A; Rosina R; Gavanaghi L
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():256-60. PubMed ID: 1840325
[TBL] [Abstract][Full Text] [Related]
17. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
[TBL] [Abstract][Full Text] [Related]
18. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
[TBL] [Abstract][Full Text] [Related]
19. Measuring unbound versus total vancomycin concentrations in serum and plasma: methodological issues and relevance.
Stove V; Coene L; Carlier M; De Waele JJ; Fiers T; Verstraete AG
Ther Drug Monit; 2015 Apr; 37(2):180-7. PubMed ID: 25072945
[TBL] [Abstract][Full Text] [Related]
20. Determination of free ertapenem in plasma and bronchoalveolar lavage by high-performance liquid chromatography with ultraviolet detection.
Gordien JB; Boselli E; Fleureau C; Allaouchiche B; Janvier G; Lalaude O; Saux MC; Breilh D
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):218-23. PubMed ID: 16290251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
